The chance of inheriting breast cancer

How likely is breast cancer to be inherited?

1. If there is a breast cancer patient among the first-degree relatives, the chance of developing breast cancer will increase by about 2 times. If two or more relatives have breast cancer, the chance of close relatives developing breast cancer will increase by about 10 times. This is especially true for some breast cancer patients who develop the disease at a younger age and with a higher degree of malignancy, for whom the genetic tendency is more obvious.

2. Breast cancer does have a genetic tendency, with a genetic inheritance probability of about 10. For patients with a family history of breast cancer, the chance of their blood relatives having breast cancer increases 24 times. Breast cancer is somewhat hereditary, with a genetic inheritance probability of about 5% to 10%. That is to say, among the breast cancer patients, about 5% to 10% of breast cancer is hereditary.

What are the drugs for breast cancer?

From the perspective of Western medicine, the commonly used drugs for treating breast cancer are basically chemotherapy drugs. At the same time, there are now many targeted therapy drugs. There are many types of chemotherapy drugs, such as the commonly used targeted drugs such as paclitaxel, doxorubicin, and cyclophosphamide.

Breast cancer is a systemic disease that requires comprehensive treatment, including surgery, chemotherapy, radiotherapy, endocrine therapy, and targeted drug therapy. There are many drugs for the treatment of breast cancer, the most common of which are paclitaxel, fluorouracil, carboplatin, etc.

How long can you live if breast cancer spreads to the bones in the late stage?

In the late stage of breast cancer, bone metastasis may occur. In cases with bone metastasis, the survival time of most patients will not exceed one year. For those with obvious bone metastasis, bone pain may occur at the metastatic site, and the symptoms may worsen at night.

For patients with bone metastasis, local radiotherapy can be used, combined with drugs such as bisphosphonates to inhibit the destruction of bone cells, control the progression of the disease, and prolong the patient's survival. If breast cancer spreads to the bones in the late stage and bone metastasis occurs, the patient will also experience obvious body pain.